Cardiac arrhythmias remain one of the most persistent burdens on global healthcare systems, and reliable pacing therapy continues to be the backbone of treatment for bradycardia and related conduction disorders. As the world's population ages and the prevalence of cardiovascular disease climbs, the demand for safer, longer-lasting, and more adaptable pacing solutions has never been greater. This growing clinical need has pushed the cardiac pacemaker market into a new era of innovation, one defined not just by smarter software and longer battery life, but by a fundamental rethink of device architecture itself.
For over six decades, the pacemaker and other heart devi...
